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IL-1β
Caspase-1COPD is a chronic airway disease associated with inﬂammation and cigarette smoking. Airway epithelial cells
are the ﬁrst cells exposed to cigarette smoke (CS) and can release CXCL-8 and IL-1β. These cytokines are
involved in acute and chronic inﬂammatory processes in COPD. The aim of this study was to investigate
whether toll-like receptors (TLRs) located in/on epithelial cells were involved in cigarette smoke-induced
cytokine production. Here we demonstrate that CS induces the release of CXCL-8 and IL-1β from human
bronchial epithelial cells (HBE-14o). CS-induced CXCL-8 production was inhibited by an antibody against
TLR4 and by inhibitory ODN suggesting the involvement of TLR4 and TLR9. In addition, exposure of HBE-14o
cells to TLR4 or TLR9 ligands resulted in the release of CXCL-8 and IL1β. TLR4 and also TLR9 were present on
the cell surface and the expression of both receptors decreased after CS exposure. The molecular mechanism
of the CS-induced CXCL-8 production by the epithelial cells was further investigated. It was found that P2X7
receptors and reactive oxygen species were involved. Interestingly, the inﬂammasome activator monosodium
urate crystals (MSU) induced the release of CXCL-8 and IL-1β and the caspase-1 inhibitor Z-VADDCB
suppressed the CS-induced release of CXCL-8. In addition, CS, CpGODN, lipopolysaccharide and MSU all
increased the expression of caspase-1 and IL-1β. In conclusion, our results demonstrate that CS releases CXCL-
8 from HBE-14o cells via TLR4 and TLR9 and inﬂammasome activation. Therefore, inﬂammasome signaling in
airway epithelial cells may play an important role in pathogenesis of diseases like COPD.D, Chronic obstructive pulmo-
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Cytokines and chemokines are importantmediators in lung defense
and inﬂammation [20]. Exposure to cigarette smoke, noxious particles
or gases can activate an inﬂammatory cascade in the airways resulting
in the production of a number of potent cytokines and chemokines [49].
The airway epithelium is the ﬁrst barrier for pathogens and particles
and is also a target for factors released by inﬁltrating inﬂammatory cells
[43]. Furthermore, airway epithelial cells are themselves potent
producers of inﬂammatory mediators by which the inﬂammation canbe initiated and sustained within the airways. Cigarette smoking and
thereby cigarette smoke is a major risk factor in the pathogenesis of
COPD [17]. Several inﬂammatory cells and their mediators participate
in the inﬂammatory response in COPD. These mediators play a role in
the induction of neutrophil inﬁltration (CXCL-8) and chronic inﬂam-
mation (IL-1β) thereby leading to tissue destruction [4,5]. CXCL-8 is
rapidly produced by different cell types upon incubation with
inﬂammatory stimuli such as TNF-α, LPS and cigarette smoke and is
one of the most potent neutrophil chemoattractants in human tissue
[14,19,30]. IL-1β induces the release of GM-CSF which leads to the
activation and increased survival of monocytes/macrophages and
enhanced oxidative burst in the lungs, thusmaintaining andprolonging
inﬂammatory reactions [48]. IL-1β is secreted after activation of
inﬂammasome signaling which is triggered by signal transduction via
TLRs and purinergic receptors [9,28]. Apoptosis associated speck-like
protein, containing a caspase recruit domain (ASC) and pro-caspase-1,
form a multimeric cytosolic molecular complex known as the NALP3
inﬂammasome [35]. Activation of cytokine receptors or pattern
recognition receptors such as TLRs leads to the induction of pro-IL-1β,
NALP3 and activation of caspase-1 [37,38] resulting in the proteolitic
release of IL-1β family cytokines [35].
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diverse microbial-derived molecules that are expressed predomi-
nantly on innate immune cells [2]. To date, eleven TLR family
members have been identiﬁed in the human genome [1]. TLR4 and
TLR9 play a critical role in lung and respiratory tract diseases
[18,46,50,51]. TLR9 is localized in intracellular compartments, and
recognizes viral and bacterial DNA that contains unmethylated CpG
dinucleotides in certain base contexts [15,44]. Ewaschuk et al.
demonstrated expression of TLR9 on the surface of intestinal
epithelial cells [12], but the presence of TLR9 on the surface of other
epithelial cell types is not well described yet.
Tobacco is known to be contaminated with microbes from which
the cell wall components, DNA or RNA might activate TLRs [33].
However, it cannot be excluded that other components in cigarette
smoke or the genetic material of the tobacco leaves contribute to
activation of TLRs. Recently, we have shown that cigarette smoke
activates TLR4 [19,40] and TLR9 signal transduction [26] in different
types of (human) immune cells. Moreover, we have reported that
cigarette smoke induces the release of adenosine-5′-triphosphate
(ATP) and activates purinergic receptor P2X7 signal transduction
pathways of human neutrophils [27]. The aims of the present study
were to evaluate whether cigarette smoke exposure: (1) induces the
release of speciﬁc chemokines and cytokines that are crucially
involved in the pathogenesis of COPD (2) alters the expression of
TLRs and (3) affects the activation of inﬂammasome in human
epithelial cells.
2. Materials and methods
2.1. Reagents
LPS (Escherichia coli 055.B5), N-acetylcysteine (NAC), curcumin,
chloroquine, propidium iodide and L-NAME were purchased from
Sigma (Sigma-Aldrich, Zwijndrecht, The Netherlands). RPMI 1640,
Tyrode's buffer, fetal bovine serum, and non-essential amino acids
were purchased from GibCo BRL Life Technologies (GIBCO-BRL-
Invitrogen Corporation, Carlsbad, CA, USA). Rabbit polyclonal anti-
bodies against IL-1β, caspase-1 and GAPDH were obtained from Cell
signaling (Bioke, Leiden, The Netherlands) and Stressgen (Enzo Life
Sciences BV, Zandhoven, Belgium), respectively. AZ11645373 (as P2X7
receptor antagonist) and ZVAD-DCB (as a caspase-1 inhibitor) were
purchased from Tocris Bioscience, (Missouri, USA) and Bachem
Distribution Services GmbH (Weil am Rhein Germany), respectively.
The precision protein standards and PVDF membrane were purchased
from Bio-Rad (Bio-Rad Laboratories, Veenendaal, The Netherlands).
Horseradish peroxidase (HRP)-conjugated rabbit anti-mouse IgG and
goat anti-rabbit IgG were purchased from Dako Diagnostics (Dako B.V.
Heverlee, Belgium). CpGODN 2395 stimulatory oligonucleotide, nega-
tive blocking control inhibitory ODNwithout the CpGmotif (inhibitory
ODNwith sequence5′-tttagggttagggttagggtt agg g-3, ODNcontrol (ODN
2395 control with sequence 5′-tgctgcttttggggggcccccc-3′) and MSU (as
a stimulator for inﬂammasome signaling) were purchased from
Invivogen (Cayla-InvivoGen Europe, Toulouse, France).
Functional neutralizing anti-TLR4 was purchased from eBioscience
(NatuTec GmbH, Frankfurt, Germany).
2.2. Airway bronchial epithelial cell culture
The 16 HBE-14o human bronchial epithelial cell line was kindly
provided by Dr. Gruenert (University of California at San Francisco,
San Francisco, CA) [6]. Cells were grown in a MEM culture medium
containing 0.292 g/L L-glutamine, 1 g/L glucose, 2.2 g/L NaHCO3 and
10% fetal bovine serum (FBS) and antibiotics (complete culture
medium) mixed with Vitrogen 100 (3 mg/ml Collagen I, bovine) and
human ﬁbronectin (1 mg/ml) in 75 cell culture ﬂasks. At conﬂuence,
cells were washed with PBS and quiesced overnight in serum-freeMEM-ITS [basal MEM containing 2 mM L-glutamine and antibiotic/
antimycotic (100 U/ml penicillin G, 100 mg/ml streptomycin, 250 ng/
ml amphotericin B (antibiotic–antimycotic liquid supplement (Invi-
trogen) supplemented with 10 mg/ml bovine insulin, 5.5 mg/ml
human transferrin and 5 ng/ml sodium selenite (Sigma). Before
each experiment, cells were washed by adding 500 μl per well of
PBS/saline, and thereafter 250 μl of fresh, serum-free MEM-ITS was
added to each well.2.3. Preparation of cigarette smoke extracts (CSE)
CSE was prepared as described previously [19]. CSE was generated
by theburningof commercially available Lucky Strike cigaretteswithout
ﬁlter (British–American Tobacco, Groningen, The Netherlands), using
the TE-10z smoking machine (Teague Enterprises, Davis, CA, USA)
which is programmed to smoke cigarettes according to the Federal
Trade Commission protocol (35-ml puff volume drawn for 2 s, once per
minute). Themachine producedmain- and side stream smoke fromone
cigarette through a 5-ml culture medium (RPMI without phenol red).
The absorbance was then measured using a spectophotometer and the
media were standardized to a standard curve of CSM concentration
against absorbance at 320 nm. The pH of the resultant extract was
titrated to pH 7.4 and diluted withmedium. This concentration (optical
density [OD]=4.0) was serially diluted with untreated media to 0.03,
0.06 and 0.12 OD and applied to the cells. Except for the dose–response
and viability test, CSMat a concentration of 0.06ODwas selected for use
in all experiments. Toxic concentrations of CSE were detected by
performing different toxicological assays (as described in Cell viability
assay section).2.4. Pharmacological interaction of inﬂammasome and ROS/NO pathways
Cells (1×106/ml) were preincubated with AZ11645373 (100 nM)
[23] or ZVAD-DCB (10 μM) [3] for 30 min before incubation with CSE.
In another experiment cellswere preincubated for 30 minwith L-NAME
(10 mM)(as ablocker for generation ofNO)andNAC(10 mM)(as aROS
scavenger). In all conditions after preincubation cells were stimulated
with CSE (1.5%) for 16 h, the supernatant harvested, and the level of
CXCL-8 determined by ELISA.2.5. Stimulation of cells
Cells (1×106 cells/ml) were incubated with various concentrations
of CSE (0.75–3%) for 16 h. Cells were simultaneously activated with
CpGODN type C (3 μM) or control ODN (5 mM), LPS (1 μg/ml), or MSU
(0.2 mg/ml) (as an activator for inﬂammasome signaling) for 16 h. The
level of cytokines was measured in the supernatant of harvested cells.
Next, cellswere preincubatedwith anti-human TLR4 (cloneHTA125) or
mouse IgG2a isotype control (20 μg/ml) or inhibitory ODN (10 mM)
(Invivogen) for 30 min or 1 h at 37 °C to study the involvement of anti-
TLRs on CXCL-8 production. Lastly, cells were stimulated with CSE
(1.5%), LPS (1 μg/ml) or CpG (3 μM) for 16 h. The supernatant was
collected and stored at−20 °C prior to cytokine quantiﬁcation.2.6. Quantiﬁcation of CXCL-8 and cytokines assay
CXCL-8 concentrations in the cell supernatant were quantiﬁed
using ELISA (BD Biosciences Pharmingen, Breda, The Netherlands)
according to the manufacturer's instructions. The production of other
inﬂammatory cytokines (TNF-α, IL-6, IL-1β and GM-CSF) was also
measured in culture medium using Bio-Plex (Invitrogen) according to
the manufacturer's instructions.
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HBE-14o cells were plated at a density of 5×106 cells/ml in 6-well
cell culture plates and stimulated (as described earlier) for 6 h. Cells
were washed twice with PBS and lysed with lysis buffer containing
20 mM Tris pH7.5, 1%Triton X-100, 100 mM NaCl, 40 mM NaF, and
1 mM EDTA with protease inhibitors (MiniTM protease inhibitors,
Roche Diagnostics). Cells were subsequently lysed on ice for 5 min
and following centrifugation at 3500×g for 5 min, the supernatants
(whole cell extracts) were collected and frozen at −70 °C.2.8. Western blot analysis of inﬂammasome signaling
The protein concentration was determined by BCA protein assay kit
(Pierce). The lysate (25 μg) was subjected to SDS/PAGE [10% (w/v) gel].
The separated proteins were electroblotted on PVDF membranes (Bio-
Rad). Membranes were then washed once with Tris/HCI, pH 7.4,
containing 159 mMNaCI and 1% Tween 20 (TBS-T), and then blocked in
super-blocking buffer (Pierce) for 1 h. After washing the membranes
with TBS-T, antibodies against IL-1β and caspase-1 were added for 24 h
at 4 °C as indicated by the supplier. After three washes with TBST,
membranes were treated for 1 h with HRP-conjugated goat anti-rabbit
IgG for IL-1β and rabbit anti-goat IgG for Icaspase-1 diluted to 1:20,000
in TBS-T. After threewasheswith TBS-T, immunoreactive protein bands
were revealed with an enhanced chemiluminescence Western blot
analysis system (Amersham Pharmacia Biotech). Films were scanned
and analyzed on a GS7-10 Calibrated Imaging Densitometer equipped
with Quantity One v. 4.0.3 software (Bio-Rad).
For detection of equal loaded protein on the gel, the membranes
were stripped with stripping buffer (Pierce), incubated with antibody
to GAPDH as a housekeeping protein and visualized by ECL.2.9. FACS analysis
Cells (1×106/ml) were incubated with CSE (1.5%) or CpGODN
(3 μM), and LPS (1 μg/ml) for 2 h, then stained with phycoerythrin
(PE)-conjugated anti-human TLR9 Ab (eB72-1665, ebioscience) or a
PE-Rat IgG2a class-matched irrelevant Ab (eBioscience) as control,
PE-TLR4 Ab (12–9917, ebioscience) or PE-mouse IgG2a for 30 min in
immunoﬂuorescence buffer (PBS 1%, FBS 1% and sodium azide 0.1%)
on ice. Then cells were washed three times with immunoﬂuorescence
buffer and 10,000 cells were analyzed on a FACSCanto ﬂow cytometer
(Becton Dickinson, USA). The results obtainedwith speciﬁc antibodies
were compared with those using isotype-matched control antibodies
in parallel. For intracellular TLR9 staining, cells were ﬁxed in ﬁxation
buffer (Becton Dickinson) for 10 min and then, after washing with
permeabilizing buffer (Becton Dickinson), incubated for 30 min with
TLR9 antibody in permeabilizing buffer.2.10. Cell viability assay
Viability of cells was determined by staining cells with Annexin-V
or 7-ADD by ﬂow cytometry analysis (FACS) as described before [42].2.11. Statistical analysis
All conditions were performed in triplicate, and all experiments
were repeated up to ﬁve times. Results are presented asmean±S.E.M.
Data from two conditions, such as between stimulated and control
samples, were compared using the unpaired 2-tailed, student's t-test.
Analyses were performed using GraphPad Prism (version 2.01).
Results were considered statistically signiﬁcant when pb0.05.3. Results
3.1. CSE induces cytokine production by HBE-14o cells
CSE induced the release of CXCL-8 from HBE-14o cells in a
concentration-dependent manner (Fig. 1A and B). 3% CSE slightly
affected the viability of the cells, an effect which was not observed
with 1.5% (data not shown). Therefore, 1.5% (OD 0.06) was used in all
subsequent experiments. CSE exposure also induced the release of
signiﬁcant amounts of IL-1β, GM-CSF and IL-6 (Fig. 1C, D, and E) but
not IL-10 (Fig. 1F) and TNF-α (data not shown).
In addition, the effects of LPS (TLR4), CpGODN (TLR9) and MSU
(inﬂammasome activators) on cytokine release were examined.
Stimulation of HBE-14o cells with LPS, CpGODN and MSU resulted
in the release of CXCL-8 and IL-1β, as well as IL-6 (Fig. 1B, C and E) but
not IL-10 (Fig. 1F). CpGODN, like CSE, induced a signiﬁcant release of
GM-CSF (Fig. 1D).
3.2. CXCL-8 production by CSE is mediated by inﬂammasome and TLRs
signaling
To explore whether CSE regulates CXCL-8 production via inﬂam-
masome signaling we incubated cells with AZ11645373 (100 nM) or
Z-VAD-DCB (10 μM). Preincubation of the HBE-14o cells with
AZ11645373 or Z-VAD-DCB inhibited the release of CSE-induced
CXCL-8 production (Fig. 2). These results are indicative for involve-
ment of inﬂammasome signaling in production of CXCL-8.
Next, the involvement of ROS and NO in the production of CXCL-8,
cells was studied. As shown in Fig. 2 preincubation of cells with L-NAME
and NAC abrogated the release of CXCL-8 induced by CSE.
In previous studies we demonstrated that CSE exposure of human
macrophages and human neutrophils can activate TLR4 and TLR9
resulting in the release of CXCL-8 [19,26,41]. Next the involvement of
these receptors in CSE-induced CXCL-8 production fromHBE-14o cells
was investigated. Pretreatment of HBE-14o cells with anti-human
TLR4 neutralizing antibody partially blocked CXCL-8 secretion in
response to CSE (Fig. 3), while no inhibition was observed when the
cells were preincubated with mouse IgG2a isotype control (Fig. 3). To
investigate the involvement of TLR9, cells were preincubated with
inhibitory ODN without a CpGODN motif which resulted in a
suppression of the CSE-induced CXCL-8 production by HBE-14o cells
(Fig. 3). LPS and CpGODN served as positive controls in these experi-
ments (Fig. 3).
3.3. Cigarette smoke modulates inﬂammasome signaling by stimulation
of caspase-1 and maturation of IL-1β expression
To determine whether the CSE components are capable of
inducing caspase-1 activation, cells were stimulated with either CSE,
CpGODN or MSU or the positive control LPS. Cell lysates were then
prepared and analyzed for caspase-1 activation and IL-1β expression.
CSE induced an up-regulation of the expression of caspase-1 and IL-1β
(17 KD) in HBE-14o cells (Fig. 4A and B). Similar results were obtained
with CpGODN, LPS and MSU (Fig. 4A and B).
3.4. HBE-14o cell regulation of TLR4 and 9 expression via CSE
The expression of TLR4 and TLR9 was determined on whole and
permeabilized HBE-14o cells to determine the location (cell surface or
intracellular) of these receptors (Fig. 5). HBE-14o cells did express
TLR4 on their cell surface membrane which was signiﬁcantly
decreased after CSE exposure (Fig. 5A). Similar results were obtained
after LPS exposure but not after CpGODN exposure (Fig. 5A). It is
generally accepted that TLR9 is expressed inside cells. However,
intestinal epithelial cells have been shown to express surface TLR9 on
their surface [12]. In the present study we demonstrated that human
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various concentrations of (A) CSE or (B–F) CSE (1,5%), MSU (1 μg/ml), LPS (1 μg/ml), CpGODN (3 μM) for 16 h. Levels of CXCL-8 (A, B), IL-1β (C), GM-CSF (D) IL-6 (E) and IL-10 (F) in
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Fig. 2. Effects of pharmacologic inhibitors for release of CXCL-8 by HBE-14o cells. HBE-
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medium and were left untreated or pretreated with L-NAME(10 nM) or NAC (10 nM),
AZ11645373 (100 nM) and ZVAD-DCB (1 μM) for 30 min and then stimulated with CSE
(1.5%) for 16 h. Levels of CXCL-8 in supernatants were measured by ELISA and values
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with CSE alone.
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We also found that CSE signiﬁcantly decreased the surface expression
of TLR9, an effect which was not observed with LPS or CpGODN
(Fig. 5C). The down-regulation of TLR4 expression on the surface of
epithelial cells by CSE and LPS could be explained by internalization.
Indeed, the TLR4 expression was increased in permeabilized cells
(Fig. 5B). In contrast, such an effect was not observed for TLR9
(Fig. 5D).
4. Discussion
Full understanding of the molecular mechanisms underlying the
development of COPD remains incomplete, but in vitro studies using
human airway epithelial cells may contribute to furthering our
understanding of this disease. Toxic substances in cigarette smoke are
able to activate diverse signal transduction pathways and induce
inﬂammatory mediators in the lungs. Thus, exploring each compart-
ment of the respiratory system individually will help unravel each step
of the patho-physiological processes behind lung emphysema. Hence,
studying airway epithelial cells, that maintain mucosal integrity and
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were left untreated or pretreated with naturalizing antibodies against TLR4 (20 μg/ml) or isotype control IgG, inhibitory ODN without CpGODN motif (25 mM) or control ODN
(5 mM) for 30 min and then activated with CSE (1.5%), LPS (1 μg/ml) or CpGODN (3 μM) for 16 h. Levels of CXCL-8 in culture supernatants were measured by ELISA as described in
Material and methods. Assays were performed in duplicate three times. Values are expressed as mean+/−S.E.M. (n=3). *p≤0.05, **p≤0.01 signiﬁcantly different compared to
control, # p≤0.05, ## p≤0.01 signiﬁcantly different compared to CSE and Ψ Ψ p≤0.01 signiﬁcantly different to LPS and Π p≤0.05 signiﬁcantly different compared to CpGODN.
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information.
COPD is a chronic disease which is driven by neutrophilic
inﬂammation. Amongst other cytokines, it has been well recognized
that one of the most prominent chemokines in COPD is CXCL-8. The
levels of this chemokine are increased in sputum from COPD patients
and correlate with the increased number of neutrophils found in the
lungs [14,17]. More recently, IL-1β has received special attention,
since this cytokine is involved in the prolonged and sustained
inﬂammatory responses. The role of IL-6 in the pathogenesis of lung
emphysema and COPD is suggested by studies showing that high
amounts of serum or sputum IL-6 are related to impaired lung
function or a faster decline in lung function in COPD patients [10,49].
Here, we demonstrated that CSE induced the production of IL-6 by
HBE-14o cells. This response was not seen with human neutrophils
[26], macrophages [40] and dendritic cells [29] and may therefore be
speciﬁc to epithelial cells.
CXCL-8 and IL-1β can be released via the stimulation of TLRs.
Previously, we demonstrated that cigarette smoke releases chemokines
and cytokines from human inﬂammatory cells via TLR signaling. In thisA
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epithelial cells to cigarette smoke and studied the interaction of TLRs
and inﬂammasome signaling. We have demonstrated that CSE induces
the production of CXCL-8, IL-1β and IL-6 from human bronchial
epithelial cells. Comparable results were found with TLR4 and TLR9
ligands and an inﬂammasome activator. Inﬂammasome/caspase-1
signaling is important for the maturation and production of IL-1β [38].
Moreover, it was demonstrated that IL-1β is involved in the production
of CXCL-8 by bronchial epithelial cells via direct activation or by
prolonging the half-life of CXCL-8 mRNA [11,32]. CSE also increased the
production of IL-1β and GM-CSF. Although, CXCL-8 was increased as
well, this does not indicate a causal relationship.
It is generally accepted that DAMPs and PAMPs induce IL-1β
expression in human monocytes [36]. We found that CSE induces 1)
the release of IL-1β and 2) the release of CXCL-8 via TLR4, 9 and
inﬂammasome activation from HBE cells. Thus, we can draw the
conclusion that airway epithelial cells play a critical role in initiation
and maintaining of lung disorders induced by cigarette smoke. The
release of CXCL-8 after CSE incubation of human bronchial epithelial
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a representative of at least 3 experiments showing the mean ﬂuorescence intensity (MFI) difference of each group. Values are expressed as mean+/−S.E.M. *p≤0.05, **p≤0.01
signiﬁcantly enhanced compared to control; # p≤0.05 signiﬁcantly reduced compared to control (stained cells). The bars indicate themeans and the error bars indicate the standard
deviations of triplicate measurements obtained in three separate experiments. NCon: non treated control (unstained cells).
1109E. Mortaz et al. / Biochimica et Biophysica Acta 1812 (2011) 1104–1110However, a blocking peptide against TLR4 did not suppress the release
of CXCL-8 [31]. In contrast, using human inﬂammatory cells and TLR
transfected cells, we demonstrated that TLR4 and TLR9 are involved in
CSE induced cytokine production [19,26]. Moreover, we showed that
the release of CXCL-8 induced by CSE was suppressed when TLR4
neutralising antibodies were applied. There could be a discrepancy
between the use of an antibody against TLR4 and the TLR4 blocking
peptides [31]. Besides, regulatory effects by CSE of TLR4 expression on
human epithelial cells (up-regulation by increasing the production)
and macrophages (down-regulation of surface and up-regulation of
intracellular levels) has been reported [31,41]. In addition, we have
shown that CSE decreased the surface expression of TLR4 on HBE-14o
cells. This could be due to internalization of the receptors after CSE
exposure, an explanation supported by the higher expression of TLR4
in permeabilized cells.
TLR9 recognizes bacterial and viral DNA, and studies using
synthetic single-stranded ODNs deﬁned the immunogenic sequences
of bacterial DNA recognized, consists of unmethylated CpG motifs in
the context of species-dependent surrounding sequences [21,24].
TLR9 is expressed primarily in antigen presenting cells such as B cells
and dendritic cells. Several lines of evidence suggest that the
molecular recognition of CpGDNA occurs inside the cell, perhaps in
lysosomes. In contrast to other TLRs, TLR9 has not been detected on
the surface of cells and TLR9 and CpGDNA localize to a common
intracellular compartment [16]. Ewaschuk et al. were the ﬁrst to
describe a surface expression of TLR9 on intestinal epithelial cells [12],
and now we have also demonstrated that TLR9 is expressed on the
surface of human bronchial epithelial cells. It can be speculated that
TLR9 is expressed on the outermembrane due to the strategic position
of intestinal and airway epithelial cells in relation to microbes. TLR9
surface expression is decreased after CSE stimulation, an effect whichwas not observed with LPS or CpGODN. Unlike TLR4, the decrease in
TLR9 surface expression could not be explained by internalization
since there was no difference in TLR9 expression between control and
CSE exposed permeabilized cells.
We then wanted to investigate the molecular pathways leading to
CXCL-8 production after TLR stimulation by CSE. In previous studies it
wasdemonstrated that reactive oxygen species and the purinergic P2X7
receptor were involved in CSE-induced CXCL-8 release by human
neutrophils [26,27]. Indeed, ROS pathway inhibitors (L-NAME andNAC)
and the purinergic receptor antagonist AZ1164 partly prevented CSE-
induced CXCL-8 production, indicative of the involvement of these
pathways in the production of CXCL-8 by CSE. This was further
conﬁrmed by using the caspase-1 inhibitor ZVAD-DCB, which reduced
the CXCL-8 production by 70%. In addition, the protein expression of
caspase-1 was increased in HBE-14o cells after CSE stimulation.
P2X7 is a receptor for ATP and impacts on many signal transduction
pathways, including the inﬂammasome [9].We found that the release of
CXCL-8 was suppressed by a P2X7 receptor antagonist. Earlier studies
demonstrated that extracellular ATP is a strong IL-1β-releasing agent for
macrophages [7]. Evidence based on in vitro and in vivo studies with
P2X7R−/−mice identiﬁed the receptor responsible for ATP-dependent
IL-1β release as the P2X7 receptor [13,22,45].
The most pronounced expression of IL-1β was observed with CSE
(as compared with CpGODN and MSU) which might be explained by
the fact that CSE stimulates both TLR4 and TLR9 and contains more
products that may interfere with cell signaling. Generation of reactive
oxygen species is considered a crucial element for NLRP3 (inﬂamma-
some signaling) activation [47]. Moreover, activation of NALP3 leads
to release of IL-1β from cells, thus it can be suggested that CSE by
induction of ROS, activation of TLR4 and TLR9 and inﬂammasome
signaling induces CXCL-8 production.
1110 E. Mortaz et al. / Biochimica et Biophysica Acta 1812 (2011) 1104–1110CXCL-8 and IL-1β are considered as important mediators in the
pathogenesis of COPD [34]. Reduction in IL-1β also resulting in
reduced CXCL-8 levels may suppress the inﬂux and activation of
neutrophils thereby breaking the sustained inﬂammatory condition in
COPD. It is well recognized that tobacco, due to fermentation, is
contaminated with microbes from which the cell wall components
(LPS), DNA or RNA can activate TLRs [33,39]. In conclusion, human
bronchial epithelial cells incubated with cigarette smoke results in the
release of IL-1β and the expression of caspase-1which is indicative for
inﬂammasome activation.
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